APA (7th ed.) Citation

Keith, R. L., Blatchford, P. J., Merrick, D. T., Bunn, P. A., Bagwell, B., Dwyer-Nield, L. D., . . . Miller, Y. E. (2019). A Randomized Phase II Trial of Pioglitazone for Lung Cancer Chemoprevention in High-Risk Current and Former Smokers. Cancer prevention research (Philadelphia, Pa.), 12(10), 721-730. https://doi.org/10.1158/1940-6207.CAPR-19-0006

Chicago Style (17th ed.) Citation

Keith, Robert L., Patrick J. Blatchford, Daniel T. Merrick, Paul A. Bunn, Brandi Bagwell, Lori D. Dwyer-Nield, Mary K. Jackson, Mark W. Geraci, and York E. Miller. "A Randomized Phase II Trial of Pioglitazone for Lung Cancer Chemoprevention in High-Risk Current and Former Smokers." Cancer Prevention Research (Philadelphia, Pa.) 12, no. 10 (2019): 721-730. https://doi.org/10.1158/1940-6207.CAPR-19-0006.

MLA (9th ed.) Citation

Keith, Robert L., et al. "A Randomized Phase II Trial of Pioglitazone for Lung Cancer Chemoprevention in High-Risk Current and Former Smokers." Cancer Prevention Research (Philadelphia, Pa.), vol. 12, no. 10, 2019, pp. 721-730, https://doi.org/10.1158/1940-6207.CAPR-19-0006.